Target intelligence / Profile preview

CD4+ T-cell receptor recognizing influenza-derived peptides presented by MHC class II (CD4+ TCR (Influenza/MHC-II))

Target
CD4+ TCR (Influenza/MHC-II)
Molecular classification
Receptor, T-cell receptor, Heterodimeric protein complex, Antigen-recognition complex
01

Overview

The CD4+ T-cell receptor (TCR) recognizing influenza-derived peptides presented by MHC class II is a fundamental mediator of the adaptive immune response to influenza virus infection. These TCRs are heterodimeric proteins that specifically bind to viral peptide fragments, such as those from hemagglutinin (HA) or nucleoprotein (NP), which are displayed by Major Histocompatibility Complex (MHC) class II molecules on the surface of antigen-presenting cells [PubMed: 28253175]. Upon recognition, the TCR initiates signaling pathways that lead to the activation and differentiation of CD4+ T cells into various effector subsets, including Th1 and T follicular helper (Tfh) cells [NIH: PMC4104054]. These cells are vital for providing 'help' to B cells for high-affinity antibody production and for enhancing the memory response of CD8+ cytotoxic T cells [PubMed: 31164461]. In clinical practice, this target is the focus of vaccine development, where the goal is to elicit TCR-mediated recognition of conserved viral epitopes to provide broad protection against multiple influenza strains [Nature: 10.1038/s41541-021-00354-z]. Therapeutic challenges include the high degree of HLA polymorphism in the human population, which dictates which peptides can be presented to these TCRs [PubMed: 25231621]. Furthermore, improper activation of these T cells can contribute to excessive inflammation or potential cross-reactivity with host tissues. Monitoring the frequency and specificity of these TCRs serves as a key biomarker for assessing vaccine efficacy and natural immunity.

Other names
Influenza-specific CD4+ T-cell receptorMHC class II-restricted influenza TCRTCR-MHC II influenza complexInfluenza-reactive CD4+ TCR
02

Mechanism of action

Activation of CD4+ T cells through the recognition of specific influenza-derived epitopes presented by MHC class II molecules, which triggers cytokine release and coordinates B-cell and CD8+ T-cell responses to clear the virus and establish immunological memory.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionB-cell helpImmunological memory
04

Disease associations

Infection (Influenza)Inflammation
05

Safety considerations

Cytokine release syndromeOriginal antigenic sin (interference from prior immunity)HLA-linked non-responsiveness due to MHC polymorphismPotential for molecular mimicry leading to autoimmunity
06

Interacting drugs

Fluzone (Influenza Vaccine)

4 more in the full profile.

07

Biomarkers

MHC-II peptide tetramer bindingIFN-gamma ELISpotTCR repertoire sequencing (TCRB)Intracellular cytokine staining (ICS)CD4+ T-cell proliferation index

Beyond the preview

Go deeper on CD4+ T-cell receptor recognizing influenza-derived peptides presented by MHC class II (CD4+ TCR (Influenza/MHC-II)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4+ T-cell receptor recognizing influenza-derived peptides presented by MHC class II (CD4+ TCR (Influenza/MHC-II)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call